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Abstract
Cerumen or earwax is an emerging bio-fluid in clinical diagnosis that has been very little exploited during the past decades in spite of its high dia-
gnostic potential. It is highly abundant in diagnostic biomarkers such as genetic material, lipids, proteins, chemical elements, internal and external 
metabolites (e.g. hormones, volatile organic compounds, amino acids, xenobiotics etc.) reaching earwax from the blood circulation. Thus, it is able 
to reflect not only physiology, pathophysiology of the human body but can also detect recent and long term exposure to environmental pollutants, 
without the need of invasive blood tests and in the same time overcoming many disadvantages faced by using other diagnostic biological fluids. 
This review discusses the biology, functions, chemistry of earwax, past and current approaches for the study of its chemical composition, emphasi-
zing how a detected variation in its composition can offer information of high clinical value, which can be useful in diagnosis of many diseases such 
as metabolic disorders and tumours as well as in forensic applications. It also presents details about techniques of sample collection, storage, and 
analysis. Moreover, it highlights concerns about the use of earwax for diagnostic purposes, which should be addressed to make earwax diagnostics 
a reality in the future.
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Cerumen, commonly referred to as earwax, is a 
rich biological fluid that has distinct advantages as 
a biomonitoring medium of a high diagnostic po-
tential. Although many studies have been con-
cerned with the elucidation of the chemical com-
position of cerumen, the literature shows that until 
today very little attention has been dedicated to 
the analysis of cerumen with the aim of laboratory 
diagnosis. Cerumen, being composed of a large 
diversity of biomarker compound classes includ-
ing lipids, proteins, amino acids (AA), carbohy-
drates, volatile organic compounds (VOC), chemi-
cal elements in addition to hormones, antibodies, 
enzymes and their products, makes it a reflection 
of the physiological functions of the body and a 
potential alternative biological matrix. This review 
provides an overview of the biology, functions of 
cerumen, past and current investigations per-
formed on its chemical composition and its appli-
cations in laboratory diagnosis with emphasis on 
pre-analytical, analytical, and post analytical as-
pects. It also highlights its advantages and limita-
tions in comparison to classical fluids.
Composition and functions of cerumen 
Cerumen is a waxy substance secreted by cerumi-
nous “apocrine sweat” glands located subcutane-
ously in the external ear canal (1,2). Ceruminous 
glands in combination with the sebaceous glands 
produce earwax which is therefore, considered a 
mixture of sweat secretions and fatty material 
from the sebaceous glands (1,2). Regarding the 
chemical composition, it is composed of fatty ac-
ids, alcohols, ceramides, wax esters, triacylglycer-
ols, long chain hydrocarbons, and cholesterol pre-
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cursors as lanosterol, squalene, and cholesterol 
which are the final products in the hyroxymethyl-
glutaryl-CoA (HMG-CoA) reductase pathway (3) 
with physical consistency ranging from wet, sticky 
and yellow or brown to dry, crumbly and white or 
greyish. Earwax production is affected by some 
factors such as working conditions, climate, and 
even increased cholesterol concentrations can 
block the HMG-CoA reductase pathway by nega-
tive feedback (2,4-5).
The earwax phenotype is determined by two al-
leles at a single gene termed as ABCC11 gene (6). A 
single-nucleotide polymorphism (SNP) in this 
gene encodes an ATP-driven efflux pump protein 
responsible for the variation in the apocrine gland 
secretion which affects the earwax type being wet 
or dry as well as the axillary odour commonly 
called “underarm odour” (6,7).
The earwax phenotype was also linked to ethnici-
ty/race, where the dry type is commonly prevalent 
in East Asians (95%) but rare in Europeans and Afri-
cans (3%). A mixed rate of dry and wet types with 
dry wax incidence of 30-50% is seen in popula-
tions of Native North Americans, the Pacific Is-
lands, Central Asia, Turkey and those of Asian an-
cestry (8,9).
Among its main functions is to moisten, clean, lu-
bricate, and protect the skin of the human ear ca-
nal, in addition to acting as an antibacterial main-
taining the environment in the ear canal acidic 
and a barrier against foreign substances as water, 
insects and dust (10). Moreover, it can provide im-
portant information about an individual including 
race, ethnicity, gender, diseases, food eaten and 
exposure to surrounding environmental pollut-
ants (11). 
Cerumen and implications to health, 
diagnostics and forensics
Cerumen sampling, transport and 
preservation
Cerumen, being secreted inside the ear canal, is 
protected against external contamination which is 
a serious problem limiting the diagnostic potential 
of many biological samples. Despite this fact, cer-
tain precautions must be considered during sam-
ple collection to maximize the credibility of data 
obtained upon its analysis as: performing hand hy-
giene, using disposable gloves and apron during 
sample collection, swabbing/removing cerumen 
from the inner portion of the ear as opposed from 
the lobes (where soap/shampoo flakes are more 
prevalent), transferring the sample to vials/con-
tainers that are air tight and at low risk of cross 
contamination, putting a label with patient infor-
mation; transportation to the laboratory for analy-
sis (12,13).
For cerumen sampling, different techniques were 
applied depending on the quantity required for 
analysis including for instance ear swabs common-
ly applied in forensic testing, DNA paternity test-
ing, etc. (14). Ear swabs could be performed at 
home by oneself placing a sterile swab (cotton 
buds or Q-tips) into the inner portion of the ear 
and gently rotating to collect the sample 2-3 times 
if possible (the more the better), whereas a full 
swab tip may be enough (14). Other techniques for 
sample collection were applied using tools such as 
sterilized metal scoops, plastic curettes, wooden 
spatulas, and the Jobson-Horne probe (15-18). Ear 
scoops (picks) are more efficient in the removal of 
the dry type of earwax, while the Jobson-Horne 
probe (Figure 1) being fenestrated is effective in 
the removal of either the dry or moist-type (18,19). 
Generally, use of ear picks is better done by a 
health professional to avoid risks of damaging the 
ear and causing infections (20).
The sampling time required to obtain samples 
with detectable concentrations involving casual 
cerumen is variable. Normally, the subjects in-
volved are instructed not to clean the ears one 
week to ten days to allow for sample build up be-
fore collection and to bathe/shower with fra-
grance-free liquid soap/shampoo, and avoid any 
kind of perfume or fragrance, in order not to affect 
the earwax volatile composition (21). In case of 
fresh cerumen sample, first casual cerumen is re-
moved from the ears of the study participants; 
then the ears are irrigated with water and wiped 
with cotton swabs moistened with an alcohol-
ether (3:1) mixture then the fresh cerumen is col-
lected 24 or 48 hours later (21).
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Samples are stored in sterile airtight containers (vi-
als, bottles, Eppendorf tubes, etc.) kept away from 
sunlight, chemicals or conditions that may cata-
lyse sample degradation (13,21,22). As for sample 
transport and preservation, the conditions are de-
pendent on the nature of the compounds being 
analysed. For instance, in case of ear swabs for 
DNA testing, the sample can be shipped to the 
laboratory in a paper envelope and stored some-
where safe at room temperature for up to six 
months (14). In case of analysis of volatile organic 
composition; samples are usually stored in a deep 
freezer at - 30 °C and analysed within one week to 
minimize the loss of the volatiles, while those used 
for lipidomics and proteomics are usually pre-
served at - 18 °C and - 80 °C, respectively (15,17,21). 
For samples that need immediate refrigeration/
freezing, they can be kept in portable freezers 
with controllable temperatures available at the 
collection sites until transported to the laboratory 
(16).
Proposals were sought to enhance the use of dried 
biological samples, one of which is dried cerumen 
for clinical analyses with the aim of enhanced re-
covery of analytes and automated processing of 
dried specimen samples - particularly if elements 
of integrated sample preparation are necessary to 
preserve the recovery of integrity of a given bio-
marker class for later detection (23).
Analysis of cerumen 
Cerumen has been subjected to different kinds of 
analyses of compound classes such as lipidomic, 
proteomic, genomic and metabolomic analyses in 
addition to analysis of chemical elements, and xe-
nobiotics e.g. drugs, foreign pollutants, etc. Details 
on selected applications of cerumen analysis in 
laboratory diagnostics including compound class-
es involved, populations tested, pre-analytical, an-
alytical and post analytical aspects are shown in 
Table 1.
Lipidomics
A great deal of effort was dedicated to the study of 
the lipid composition of cerumen, both casual and 
fresh as well as the variations detected with differ-
ent earwax type, age, sex, season, menstruation 
etc. (2,4,24-30). The last approach was presented 
by Stransky et al. who performed a complete pro-
filing of the cerumen lipid components in a sam-
ple (1.323 g) collected twice a week, throughout 
one year from both ears of a healthy 65 years old 
male (17). Then gradient column chromatography 
was used to separate cerumen into the aliphatic 
hydrocarbons, squalene, wax esters, cholesterol 
esters, triacylglycerols, free fatty acids, fatty alco-
hols, monoacylglycerols, cholesterol, sterols, and 
hydroxy acids which were then analysed separate-
ly, and identified by gas chromatography (GC) and 
gas chromatography/mass spectrometry (GC/MS) 
techniques. 
Regarding the application of lipid analysis in ceru-
men, the majority of the studies of the lipid com-
position of cerumen were directed to the improve-
ment of the developed ceruminolytic agents 
(25,31-33). This is due to the fact that the epider-
mal cells constituting approximately half of the 
mass of wax impactions are enveloped in a layer of 
bound lipids (w-hydroxyacids, free fatty acids, and 
ceramides) which contribute to the cellular cohe-
Figure 1. The Jobson-Horne probe, an effective curette for the 
removal of the dry and wet type earwax
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siveness which justifies why studying the lipid 
composition in specific could be useful in the 
choice and development of new ceruminolytics 
(34,35). 
On the other hand, very little work was concerned 
with the use of cerumen lipids as diagnostic bio-
markers in laboratory diagnostics. However, in this 
review, we tried to highlight some reports poten-
tially relating cerumen lipids with some pathologi-
cal conditions, either local (inside the ear) or sys-
temic.
In 1954, Akobjanoff et al. identified some of the 
fatty acids in earwax (capric, lauric, oleic, myristic, 
linoleic, palmitic, stearic acids) as an approach to 
determine the normal constituents of cerumen 
(36). This may allow the detection of pathological 
conditions of the ear through changes from the 
normal. For instance, external otitis caused by a 
malfunction of the epidermal glands of the skin of 
the ear canal would be expected to show changes 
in the cerumen composition, which if recognized 
could be used for prophylaxis and treatment (37).
Later, Inabi et al. investigated the lipid composi-
tion in earwax of patients with hircismus using 
thin layer chromatography (TLC) (38). Samples 
were collected from 20 patients with hircismus 
(wet earwax type) and 20 adult volunteers without 
hircismus, extracted with n-hexane, and resolved 
by TLC using different solvents (hexane, benzene, 
ether, acetic acid). Spots were visualized by spray-
ing with 50% sulfuric acid and charring at 220 °C 
and the unidentified fat was further analysed by 
GC and high performance liquid chromatography 
(HPLC). Results show that wet earwax is due to the 
difference in quantity and quality of earwax lipids 
and hircismus is associated with higher incidence 
of wax lipids. For instance, in wet earwax, steryl-
esters and wax esters were not found as compared 
to dry earwax type while two unidentified lipids 
were found only in wet earwax type.
In 1966, a preliminary report undergone by a Japa-
nese research group suggested a correlation be-
tween the lipid composition of earwax represent-
ed in the earwax type with the incidence of a coro-
nary heart disease (arteriosclerosis). Based on the 
investigations performed on 96 Caucasian and 
Japanese arteriosclerotic in- and out- patients 
(with no reported age range), results showed that 
the incidence of wet cerumen among the patients 
with arteriosclerosis, not accompanied by hyper-
tension, was strikingly high (30.2%), whereas it was 
13.8% among arteriosclerotic patients with hyper-
tension (39). 
Later, in 1976, further investigations showed that 
Caucasian and Japanese populations’ dry ceru-
men contains 18% lipid and 43% protein, while 
wet cerumen has about 50% lipid and 20% pro-
tein. Since the cholesterol fraction of the lipid ma-
terial is similar, the absolute amount of cholesterol 
excreted by persons with wet cerumen is inferred 
to be greater. This supports the assumption that 
the cerumen cholesterol concentration can give 
an indication about cholesterol concentration in 
blood (40). However, unfortunately, no further re-
ports were found correlating cholesterol in ceru-
men with blood cholesterol. Moreover, modern 
methods to characterize lipids and lipoproteins do 
not seem to have been applied to cerumen and 
since it is conventional, in studies of disease asso-
ciation, to treat the first claim with due suspicion, 
therefore the relevance of cerumen types to lipid 
metabolism and arteriosclerosis remained an un-
resolved issue that can be neither asserted nor re-
jected (40).
Wet cerumen was also related to the incidence of 
Tinea vescicolor infection of the outer ear (41). Ow-
ing to its lipid composition, this type of earwax in-
creases the susceptibility to lipophilic fungus 
“Malassezia furfur” responsible for Tinea versicolor. 
Two hundred and twenty three Japanese cases of 
Tinea versicolor were examined in Kumamoto, wet 
earwax was found in 90 cases (40.9%). These re-
sults indicate a significantly higher incidence of 
Tinea versicolor among individuals with wet ear-
wax (41). 
In another approach, 67 patients with Parkinson 
disease were subjected to the examination of their 
ear canals. By examination, the ear canals of one or 
both ears of 40 out of the 67 patients were found 
to be totally blocked with grossly excessive quanti-
ties of greasy hard wax (42). This is considered typ-
ical of the disease that causes increase in the activ-
Biochem Med (Zagreb) 2017;27(3):030503  https://doi.org/10.11613/BM.2017.030503 
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ity of the sebaceous gland and thus the wax secre-
tion. Psoriasis can also cause an increase in waxy 
material in the ear (43).
Proteomics
The composition of the protein in fresh and casual 
cerumen samples was first investigated photo-
metrically by Chiang et al. (25). Later, an alpha-
2-globulin was detected in cerumen by double 
diffusion and immune-electrophoresis but the 
first description of the isolation and quantification 
of total proteins of earwax was introduced by 
Schwaab et al. (44,45). Samples at an average 
weight of 77.75 mg were collected from ears of 16 
healthy adults (wet earwax type) with a sterile 
hook under otoscopic control. Then, they were 
weighed, pulverized using a mortar and a pestle in 
liquid nitrogen. Proteins were then isolated by the 
Qproteome™ Mammalian Protein Prep Kit (Qiagen, 
Hilden, Germany) in two different kinds of ways 
(cell and lysate fraction). Afterwards, total protein 
concentration was quantified using the BCA pro-
tein assay kit (Thermo Fisher Scientific, Rockford, 
USA) method. This assay allows the colorimetric 
detection and quantitation of total protein using a 
unique reagent containing bicinchoninic acid.
The antimicrobial nature of cerumen has been in-
vestigated in relation to the levels of lysozyme and 
immunoglobulins present. Cerumen samples were 
collected by curette from 588 Caucasians, Black 
people, and Chinese; suspended in a buffer solu-
tion and mixed by a vortex mixer. Then, the 
lysozyme assay was performed as adapted from 
Osserman et al. while the antibodies were tested 
by immunodiffusion techniques set up with the ce-
rumen suspension and immunoglobulin (Ig) A/IgE 
antibody (46,47). Lysozyme and immunoglobulins 
were present in almost all samples of the dry type 
but its frequency of occurrence varies significantly 
among the wet type depending on the race (48). 
Lower lysozyme content and less acid pH in ceru-
men were also related to the occurrence of malig-
nant otitis externa (MOE), an aggressive infection 
involving the external auditory canal and tempo-
ral bone, characterized by high mortality rate, ag-
gressive disease progression and poor response to 
treatment (49).
Further study of the antimicrobial role of cerumen 
was carried out by quantitative estimation of 10 
well known human antimicrobial peptides in ear-
wax using enzyme linked immunosorbent assay 
(ELISA) (50).
Cerumen proteomic analysis was utilized for the 
first time as a non-invasive tool for biomarker anal-
ysis and disease diagnosis by Feig et al. employing 
liquid chromatographic-mass spectrometry (LC-
MS) (15). A number of 11,562 distinct peptides rep-
resenting 2013 proteins were identified in human 
cerumen. Five hundred and ninety-nine proteins 
(31%) were found unique to cerumen. Of these, 
283 were successfully identified and by comparing 
the proportions of proteins in cerumen to multiple 
bio-fluids (saliva, urine and plasma), cerumen was 
found equally efficient as a novel bio-fluid in clini-
cal diagnostics. In addition, the method allowed 
the detection of high amounts of zinc-alpha-2-gly-
coprotein, cathepsin D, apolipoprotein D, serpins, 
calpain, mucins and lysozyme C confirming the 
antimicrobial role of earwax. Thus, proteomic 
characterization of cerumen might provide expla-
nations for local pathologies of the ear such as ot-
omycosis, benign or malignant pathologies of the 
outer ear and susceptibility to recurrent infections 
such as chronic otitis externa, and can be applied 
for disease stage stratification as well. 
Apart from that, proteomic characterization of ce-
rumen could play a role in the diagnosis of system-
ic diseases where zinc-alpha-2-glycoprotein was 
already described to serve as either a potential bi-
omarker for normo-albuminuric diabetic nephrop-
athy, apocrine activity in breast cancer or a cata-
bolic marker in cancer and noncancerous states 
(51-54). Apolipoprotein D is a lipoprotein related to 
increased total hydrophobicity and decreased sus-
ceptibility to infection by transport and binding to 
hydrophobic molecules, e.g. cholesterol esters, in 
the outer ear canal (3,55). An interaction of zinc-al-
pha-2-glycoprotein and apolipoprotein D also af-
fects prolactin-inducible protein (a molecule regu-
lating water transport in apocrine glands) (56). Prol-
actin-inducible protein is used as a potential mark-
er for grading of apocrine carcinoma of the breast 
and interacts with IgG and CD4-T cell receptor (57). 
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Another glycoprotein was detected in cerumen, 
which is similar to salivary glycoprotein (EP-GP), a 
glycoprotein isolated from human saliva with 
homologues in several other body fluids (58). It 
was measured by quantitative ELISA in cerumen 
among other fluids and showed a wide variability 
while the EP-GP epitope bearing proteins were 
further characterized by electrophoresis and im-
munoblotting. The biological role of EP-GP is not 
exactly known but there were reports about its 
ability to bind different bacterial species both in 
vivo and in vitro (59). 
Genomics
Cerumen was applied for the detection of differ-
ent diseases using modern DNA testing tech-
niques, such as for detection of chronic infection 
with hepatitis B (HBV) and ability to transmit hepa-
titis C viruses (HCV) (60-62). Detailed information 
on these applications is provided in Table 1.
An association between axillary odour and the 
wet-type earwax was first established only based 
on the phenotype more than 70 years ago (7). Lat-
er, this finding was confirmed using a 
SNP(rs17822931) of the ABCC11 gene, the determi-
nant gene of the earwax types, and furthermore 
was successfully used as a diagnostic marker for 
axillary osmidrosis (AO), a clinical condition of indi-
viduals with a deep anxiety regarding axillary 
odour and had undergone the removal of bilateral 
axillary apocrine glands (7). Further genetic asso-
ciation was found between wet earwax type, 
breast cancer (63), and AO (64). For the purpose of 
fast genetic diagnosis of AO and potential risk of 
breast cancer, specific primers were developed 
that allow to clinically genotype the ABCC11 gene 
within 30 minutes (64). Further evidence was 
found on genetic association between wet earwax 
type, breast cancer, AO (63,64). Recently, a clinical 
method was developed to rapidly detect the ge-
netic polymorphism (SNP 538G_A) in the ABCC11 
gene by a SmartAmp method in ≈ 30 min which 
not only enables fast diagnosis of AO but also po-
tential risk of breast cancer genetically related to 
both wet earwax type and AO (64). Moreover, the 
SNP 538G_A responsible for the wet earwax type 
was further related to colostrum production from 
the mammary glands where the frequency of co-
lostrum occurrence and its measurable volume are 
much higher among wet-type than the dry-type 
women. This could be important to provide antici-
patory guidance for mothers about breast-feeding 
and the length of time that should be spent in 
feeding based simply on their earwax-type (65).
Metabolomics
Volatile organic compounds
Volatile organic compounds are a diverse group of 
stable carbon-based chemicals that are classified 
on the basis of their retention time and boiling 
point (ranging from 50°C to 260°C) (66). 
Earlier, very little effort has been dedicated for 
analysis of VOC in cerumen, either alone (21) or 
along with other components as ash and electro-
lytes (sodium (Na), potassium (K), calcium (Ca), 
magnesium (Mg), and phosphorus (P)) to monitor 
the change in its content in association with some 
disorders as allergic rhinitis, otoschlerosis and can-
cer (21,67). 
Recent studies have concentrated on the analysis 
of the volatile organic composition of earwax, as it 
is very lipophilic, and may act as an ideal substrate 
for retaining organic compounds indicative of 
physiological, dietary, environmental events and/
or exposures and ethnic origins (11). The earwax 
VOC profile was indicative for some metabolic dis-
eases as maple syrup urine disease (MSUD) and 
alkaptonuria, which were identified in earwax be-
fore being diagnosed using traditional techniques 
as blood and urine analysis (68-71). 
Maple syrup urine disease was diagnosed by the 
characteristic burnt sugar odour that can be easily 
detected in patients’ earwax and in neonates < 5 
days old. The smell is attributed to sotolone result-
ing from accumulation of branched chain AAs and 
2-oxocarboxylic acids. On the other hand, alkap-
tonuria could be easily diagnosed at any age by 
the black earwax and the detection of homogenti-
sic acid in samples by paper chromatography (71).
Most recently, cerumen was able to detect diabe-
tes mellitus (DM) and to discriminate between its 
types 1 and 2 by monitoring of the changes in the 
volatile composition of samples collected from 
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DM patients (types I and II) (16). Samples were ana-
lysed by headspace gas chromatography/mass 
spectrometry (HS/GC-MS) without previous ex-
traction. Significant changes were obtained in the 
alcohols and ketones profiles, principally (ethanol, 
acetone, methoxyacetone, hydroxyurea, isobu-
tyraldehyde, and acetic acid.
Amino acids
So far, AA analysis in earwax did not seem to have 
a role in medical diagnostics and the major part of 
it was dedicated to study the difference in AA 
composition between dry and wet earwax types 
as well as for development of new better cerumi-
nolytic agents (72). For the later purpose, a study 
of AA composition of earwax as well as the carbo-
hydrate content was done (31). The method em-
ploys an AA analyzer and LC with amperometric 
detection for AA and carbohydrate content, re-
spectively. Glycine, glutamic acid, and serine were 
found to be the major AA components of earwax 
while galactosamine, galactose, glucose, glucosa-
mine, mannose, and fructose were found in the 
carbohydrate part.  
Carbohydrates
For medical diagnosis, studying the carbohydrate 
content in cerumen could be important as certain 
amounts of sugars in association with a nitrogen 
source and some AAs may prove advantageous to 
the growth of pathogens, and certain pattern of 
sugars in cerumen may be indicative of tumours 
and metabolic diseases (31). Only one abstract (in 
Russian) has been provided in this regard, about 
correlation of glucose concentration in cerumen 
with DM, both latent and manifest (73).
In addition, the carbohydrate content in cerumen 
was investigated for development of new cerumi-
nolytic agents, by anion exchange column chro-
matography (CC) with pulsed amperometric de-
tection and a gold working electrode. The carbo-
hydrate analysis was performed on earplugs ob-
tained from 10 patients that needed ear pug re-
moval. The results reveal in the order of their 
abundance: galactosamine, galactose, glucose, 
glucosamine, mannose, and fructose with ratios of 
2.4, 1.0, 0.9, 0.7 and 0.3, respectively (31).
Xenobiotics 
Some studies suggest that earwax is like nails, hair 
and teeth may indicate chronic exposure since the 
last three media facilitate cumulative deposition of 
xenobiotics (74). Cerumen has been used for de-
tection of long-term exposure to bio-accumulato-
ry xenobiotics like lindane, chlordane, dichlorodi-
phenyltrichloroethane (DDT), dichlorodiphenyldi-
chlororthylene (DDE), dieldrin, hexachloroben-
zene (HCB), and hexachlorocyclohexane (HCH) 
which cause cancer mortality, using GC and GC-
MS, as well as for detection of environmental ex-
posure to metals (74-76). Despite that, the ceru-
men sampling is much simpler and acceptable 
than the surgical sampling of other adipose tis-
sues, the results can only reflect cumulative expo-
sure over a period of months or years rather than 
recent exposure and information relating to the 
chronic health effects of concern is lacking (77).
On the other hand, earwax was most recently used 
as a medium for monitoring drugs specially to in-
dicate administration of drugs of abuse or drug fa-
cilitated crimes antiepileptics, anxiolytics, antipsy-
chotics, etc. Cerumen could be even considered a 
more favourable surrogate to traditionally used 
biological fluids because of its non-invasiveness, 
ease of sample collection, minimum sample pre-
treatment, and relatively less external contamina-
tion in addition to being able to detect the ana-
lytes recently administered as well as drugs ad-
ministered some months ago (78). 
Further studies were extended to using post-mor-
tem cerumen samples for detection of drugs of 
abuse, which may be correlated with the cause of 
death as opiates, amphetamine and derivatives, 
cocaine, methadone and/or derivatives (79). Sam-
ples were collected using cotton swabs, dried at 
room temperature for 24 hours before extraction 
and analysis by (liquid chromatography/time of 
flight mass spectrometry (LC-TOF MS) and LC-MS/
MS (79).
It was also applied for detection of tobacco use/
exposure by the monitoring nicotine and its relat-
ed compounds (cotinine, anabasine and o-nico-
tine). Moreover, it was able to distinguish non- or 
passive exposure to tobacco smoke from active 
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exposure. Samples of 20 mg were collected from 
61 young adults (18-35 years) using a plastic cu-
rette and analysed directly by HS/GC-MS without 
previous extraction. Cotinine and anabasine were 
found to be the biomarkers capable of discrimi-
nating completely between the study groups due 
to the significant difference in their detected con-
centrations (80).
Chemical elements
In 1992, Krishnan et al. presented the first report of 
the use of earwax as a biological monitoring me-
dium for metals (81). Thirty-eight elements were 
analysed in cerumen samples obtained from one 
Eurasian male in his middle forties and one female 
from the Indian subcontinent in her thirties, by in-
ductively coupled plasma atomic emission spec-
troscopy (AES). Results demonstrated the non-de-
tection of silver (Ag), boron (B), beryllium (Be), co-
balt (Co), mercury (Hg), manganese (Mn), nickel 
(Ni), selenium (Se), and vanadium (V) which sug-
gests potential usefulness of earwax as a biologi-
cal monitoring medium for these toxic elements in 
people exposed to high concentrations in the en-
vironment or in the workplace, since no baseline 
correction is required unlike for the other ele-
ments. On the other hand, Pb and Cd were detect-
able in both samples which signifies possible use 
of earwax to assess their external exposure.
Later, several studies were carried out that related 
the metal content to the health status and patho-
logical conditions as cystic fibrosis, allergic rhinitis, 
otoschlerosis, cancer, and Wilson’s disease (82-84). 
For instance, cystic fibrosis patients show lower 
concentrations of all the detected electrolytes (Na, 
K, Ca, Mg, Cu, Zn), principally the later (82). 
It was also indicative of ear infections where the 
fungal growth in the ear was investigated in rela-
tion to the content of iron and copper amounts 
detected in earwax samples obtained from 10 
male and 10 female Egyptians (85). Samples were 
collected in Pyrex glass sterile tubes and micro-
chemical analysis was carried out by flame pho-
tometry. High copper concentrations were found 
in samples of some subjects indicating the ab-
sence of fungal infections while iron, which is also 
toxic for fungal growth, was undetectable in all 
the experimental samples.  
The metal content of cerumen was also used as a 
method to study the pathogen biodiversity of hu-
man cerumen by using an optical probe for metal 
content characterization (86). 
Future perspectives of cerumen analysis
A great effort needs to be done to incorporate ear-
wax diagnostics into daily use where collection 
methods and biomarkers need to be standardized 
and validated. Prospective specimen collection 
and retrospective blinded evaluation are typically 
used for this purpose to minimize bias and rein-
force significance. To fulfil these protocols prior to 
diagnosis, large patient populations, procurement 
and categorization of their samples, and clinical in-
formation are required. Cerumen is assessed quan-
titatively to determine the specificity, sensitivity, 
and reproducibility of the biomarker(s) in ques-
tion. Further evaluations are also required to ex-
plore the capability of detecting and accurately 
measuring the markers in relatively low concentra-
tions. Then before cerumen is used in a clinical as-
say, it is subjected to five stages including: 1) pre-
clinical testing where biomarkers are discovered in 
patient samples and confirmed either in vitro or in 
vivo; 2) feasibility analysis in which biomarkers are 
tested using small patient subpopulations to dem-
onstrate their ability to detect disease; 3) valida-
tion process, which involves accurate testing for 
biomarkers; 4) statistical analysis to verify if statisti-
cally significant differences were obtained in a 
large patient population; 5) investigating the bio-
chemical functions of the biomarker as under-
standing of the molecular mechanisms of bio-
markers enables them to be more informative of 
the disease, progression and potential treatments. 
In addition, new assays and devices need to be de-
veloped at a commercially feasible rate. This could 
make earwax-based diagnostic tests more accept-
ed by health care professionals, consequently fa-
cilitating the generation of further studies to dem-
onstrate and establish the accuracy, sensitivity, 
and specificity of earwax diagnostics in a much 
wider variety of diseases. This involves studying 
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for instance, the impact of interindividual varia-
tions (e.g. age, gender, heath status, racial differ-
ences, etc.), the time course of the investigated bi-
omarkers in earwax, and correlation of its levels 
with corresponding levels in blood and/or urine. 
Accomplishing this along with the establishment 
of defined guidelines for the procedures might 
make earwax diagnostics a reality in the future es-
pecially that there has been increasing applica-
tions of earwax analysis in forensics as evident in 
the recent literature. In this review, we highlighted 
some advantages and limitations of earwax as a 
diagnostic bio-fluid as shown in Table 2.
Conclusion
This review provides a summary of the biology, 
functions of cerumen, past and current investiga-
tions performed to establish biomarkers that 
could be potentially applied in disease detection 
combined with noninvasive sample collection. It 
also focuses on the potential role of earwax as me-
dium for biological monitoring and a new frontier 
for medical diagnosis and forensic applications 
highlighting its advantages in comparison to tradi-
tional diagnostic tests. It also encourages further 
research on earwax as a promising alternative bio-
logical fluid. Some limitations were found in our 
review, where relatively less data was available on 
applications of cerumen in medical diagnosis and 
some of the references could be somehow outdat-
ed. That is probably due to the fact that earwax 
until recently have been looked upon as a neglect-
ed body secretion and thus many years were 
needed to reach a considerable amount of data 
supporting the diagnostic potential of earwax.
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Advantages Limitations
Noninvasive, easy to collect, low cost Despite its accessibility, it has not been widely and sufficiently studied as a bio fluid
No/minimum external contamination 
Earwax composition shows a high inter-individual variability 
depending on many factors (sex, age, season, menstruation, 
etc.) 
No risk of disease transmission as in blood sampling Timely reproduction, since time (few days) is required for the 
build-up of the sample thus it is not suitable for continuous 
monitoring
No need for trained medical staff
Samples are easy to ship and store
No/minimum embarrassment or discomfort associated with 
blood and urine tests
Lack of standardized methods for earwax collection
Requires less sample pretreatment or manipulation for 
diagnostic tests
Can detect both recent and long-term exposure unlike blood, 
urine, saliva, etc. Till now, cerumen analysis involves complicated 
instrumentation as GC–MS, LC-MS that requires trained 
personnelEconomical sampling, shipping and storage compared to blood
Sampling can be done at home
GC-MS – gas chromatography - mass spectrometry. LC-MS - liquid chromatography-mass spectrometry.
Table 2. Advantages and limitations of earwax testing for laboratory diagnostics
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